Atlas Trials

INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer

Clinical trial NCT02764086 · TERMINATED

Trial details

NCT number
NCT02764086
Sponsor
Cancer Trials Ireland
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2016-08-10
Primary completion
2020-06-05
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.